Lainas Panagiotis, Boudechiche Lyes, Osorio Angel, Coulomb Aurore, Weber Anne, Pariente Danièle, Franco Dominique, Dagher Ibrahim
Inserm U804, University Paris-Sud, Kremlin-Bicêtre, France.
J Hepatol. 2008 Sep;49(3):354-62. doi: 10.1016/j.jhep.2008.01.034. Epub 2008 Mar 10.
BACKGROUND/AIMS: Permanent portal vein embolization (PVE) is a widely practised technique. The use of an absorbable material would be safer in clinical situations in which the embolized liver is not resected. We evaluated the efficiency of reversible PVE in terms of liver regeneration and analyzed the precise time course of portal recanalization.
Nine monkeys underwent PVE of the left and right anterior portal branches using powdered absorbable material. Repeated portograms were carried out until complete revascularization of the embolized liver. Hepatocyte proliferation rates were assessed by BrdU incorporation. Liver segment volumes were determined by CT scans performed before embolization, then 1 month and 1 year after embolization.
Reversible PVE induced significant hepatocyte proliferation in the non-embolized segments (13.5+/-1.0%, 10.5+/-0.8% and 9.1+/-2.0% of cells on days 3, 5 and 7, respectively). One month after the embolization, the non-embolized liver volume had increased from 38.4+/-1.3% to 54.8+/-0.5% of total liver volume. Proximal and complete revascularization occurred 6-8 and 12-16 days, respectively.
Reversible PVE efficiently induces liver regeneration. The use of absorbable material avoids long-term liver scarring. Such material may be suitable for several clinical indications, including cell transplantation.
背景/目的:永久性门静脉栓塞术(PVE)是一种广泛应用的技术。在未切除栓塞肝脏的临床情况下,使用可吸收材料会更安全。我们从肝再生方面评估了可逆性PVE的效果,并分析了门静脉再通的精确时间进程。
9只猴子使用可吸收粉末材料对左右肝门前支进行PVE。重复进行门静脉造影,直至栓塞肝脏完全再血管化。通过掺入BrdU评估肝细胞增殖率。在栓塞前、栓塞后1个月和1年进行CT扫描测定肝段体积。
可逆性PVE在未栓塞肝段诱导了显著的肝细胞增殖(分别在第3、5和7天,增殖细胞占13.5±1.0%、10.5±0.8%和9.1±2.0%)。栓塞后1个月,未栓塞肝脏体积从占全肝体积的38.4±1.3%增加到54.8±0.5%。近端和完全再血管化分别发生在6 - 8天和12 - 16天。
可逆性PVE能有效诱导肝再生。使用可吸收材料可避免长期肝瘢痕形成。这种材料可能适用于多种临床适应证,包括细胞移植。